Compare EMR & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EMR | BDX |
|---|---|---|
| Founded | 1890 | 1897 |
| Country | United States | United States |
| Employees | N/A | 72000 |
| Industry | Consumer Electronics/Appliances | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.8B | 49.4B |
| IPO Year | 1994 | 1998 |
| Metric | EMR | BDX |
|---|---|---|
| Price | $155.85 | $179.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | $156.47 | ★ $186.00 |
| AVG Volume (30 Days) | ★ 1.6M | 1.5M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | 1.63% | ★ 2.89% |
| EPS Growth | ★ 17.78 | N/A |
| EPS | ★ 3.45 | 1.59 |
| Revenue | ★ $24,412,000,000.00 | $21,840,000,000.00 |
| Revenue This Year | $6.09 | N/A |
| Revenue Next Year | $5.41 | $3.02 |
| P/E Ratio | ★ $44.80 | $114.79 |
| Revenue Growth | 0.78 | ★ 8.24 |
| 52 Week Low | $122.64 | $140.11 |
| 52 Week High | $166.35 | $213.08 |
| Indicator | EMR | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 52.96 | 52.46 |
| Support Level | $145.14 | $175.20 |
| Resistance Level | $165.75 | $186.99 |
| Average True Range (ATR) | 2.83 | 3.47 |
| MACD | 0.49 | -0.65 |
| Stochastic Oscillator | 77.34 | 62.32 |
Founded in 1890 as the first manufacturer of electric fans in North America, Emerson Electric has become a leading industrial automation player through the acquisition of established brands. Emerson organizes its business into seven segments that sell a wide range of automation software, power tools, and automation hardware such as valves, gauges, and switches. In recent years, Emerson divested its climate technology and consumer businesses to become more of a pure-play industrial automation company. The automation of a factory is an enticing long-term proposition for manufacturers, helping reduce accident rates and raise uptime and productivity.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.